Printer Friendly Version

Section: Radiology
Number: X-52
Topic: Virtual Colonoscopy/CT Colonography
Effective Date: January 1, 2006
Issued Date: January 16, 2006
Date Last Reviewed: 01/2006

General Policy Guidelines

Indications and Limitations of Coverage

Virtual colonoscopy, also known as CT colonography, is considered an experimental/investigational procedure. Payment is not made for this procedure. A participating, preferred, or network provider can bill the member for the denied service.

Recently published medical literature provides information on this evolving technology describing promising applications. However, further studies are needed to compare current gold-standard conventional colonoscopy or sigmoidoscopy in low-, average-, and high-risk patient populations.  The use of CT colonography in this overall population-based colon cancer screening strategy has not been clearly defined and has not shown to be cost effective in patient outcomes.

The relatively low specificity and sensitivity of virtual colonoscopy in yielding false positive results reduces its cost-effectiveness, because false positives could result in many unnecessary follow-up conventional procedures. There have been no studies evaluating the effectiveness of CT colonography in reducing morbidity or mortality from colorectal cancer. In addition, there is insufficient data to measure the frequency of complications with CT colonography.

The American Cancer Society’s (ACS) Colorectal Cancer Advisory Group concluded that evidence is insufficient to determine whether CT colonography is comparable or superior in performance to conventional colonoscopic evaluations. The ACS suggested further studies are needed before virtual colonoscopy/CT colonography is recommended for routine colorectal cancer screening.

Codes 0066T and 0067T, as appropriate, should be used to report virtual colonoscopy/CT colonography. However, some providers may report CT of the abdomen (codes 74150-74170) in conjunction with 3-dimensional and/or holographic reconstruction (codes 76376, 76377) to obtain payment. Because CT colonography/virtual colonoscopy is considered investigational, no payment should be made for this procedure under these codes.

Description

CT colonography is often referred to as "virtual colonoscopy."  This test involves pumping air into the colon, and performing a special computed tomographic (CT) study called a helical or spiral CT scan. This type of scan takes many thin pictures of the structures in the abdomen. A computer then constructs 2- and 3-dimensional images of the inside of the colon. This helps the provider detect any abnormalities that may require a closer look.

CT colonography/virtual colonoscopy requires the same type of bowel cleansing regimen prior to the study. However, CT colonography is less invasive than conventional colonoscopy. It does not carry the small but real risk of bowel perforation associated with conventional colonoscopy. It can detect larger polyps, but may not be as sensitive at detecting smaller lesions.

In some instances, virtual colonoscopy may yield a “false positive” reading, that is, a suspicious finding that turns out not to be a polyp. Unlike conventional colonoscopy, polyps cannot be removed during a virtual colonoscopy.  If a suspicious area is noted, a conventional colonoscopy or other procedure may still be necessary to diagnose and/or treat the patient.


NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

76376763770066T0067T  

Traditional Guidelines

Refer to General Policy Guidelines

FEP Guidelines

Under the Federal Employee Program, all services that utilize FDA-approved drugs, devices, or biological products are eligible when intended for the treatment of a serious or life-threatening condition and when medically necessary and appropriate for the patient’s condition. Virtual colonoscopy/CT colonography is considered eligible when determined medically necessary based on the patient’s condition.

Also refer to General Policy Guidelines

PPO Guidelines

Refer to General Policy Guidelines

Managed Care POS Guidelines

Refer to General Policy Guidelines

Publications

PRN References

04/2004, CT colonography considered investigational

References

Computed Tomographic Virtual Colonoscopy to Screen for Colorectal Neoplasia in Asymptomatic Adults, The New England Journal of Medicine, December 2003

The Future of Colorectal Cancer Screening, American Cancer Society New Today, February 2003

Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U. S. Preventive Services Task Force, Annals of Internal Medicine, July 2002

Cost-effectiveness Analyses of Colorectal Cancer Screening: A Systematic Review for the U. S. Preventive Services Task Force, Annals of Internal Medicine, July 2002

National Blue Cross Blue Shield Medical Policy Reference Manual, 6.01.32, October, 2003

View Previous Versions

[Version 001 of X-52]

Table Attachment

Text Attachment

Procedure Code Attachment


Glossary





This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Mountain State Blue Cross Blue Shield plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Mountain State Blue Cross Blue Shield (MSBCBS) retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of MSBCBS. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.



back to top